LLY

1,071.53

+0.34%↑

JNJ

205.37

-0.98%↓

ABBV

229.2

+0.63%↑

UNH

324.87

+0.03%↑

AZN

92.08

+0.63%↑

LLY

1,071.53

+0.34%↑

JNJ

205.37

-0.98%↓

ABBV

229.2

+0.63%↑

UNH

324.87

+0.03%↑

AZN

92.08

+0.63%↑

LLY

1,071.53

+0.34%↑

JNJ

205.37

-0.98%↓

ABBV

229.2

+0.63%↑

UNH

324.87

+0.03%↑

AZN

92.08

+0.63%↑

LLY

1,071.53

+0.34%↑

JNJ

205.37

-0.98%↓

ABBV

229.2

+0.63%↑

UNH

324.87

+0.03%↑

AZN

92.08

+0.63%↑

LLY

1,071.53

+0.34%↑

JNJ

205.37

-0.98%↓

ABBV

229.2

+0.63%↑

UNH

324.87

+0.03%↑

AZN

92.08

+0.63%↑

Search

West Pharmaceutical Services Inc

Aperta

SettoreSettore sanitario

274.87 -0.15

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

272.21

Massimo

276.59

Metriche Chiave

By Trading Economics

Entrata

8.2M

140M

Vendite

38M

804M

P/E

Media del settore

40.335

76.798

EPS

1.96

Rendimento da dividendi

0.31

Margine di Profitto

17.406

Dipendenti

10,600

EBITDA

19M

217M

Raccomandazioni

By TipRanks

Raccomandazioni

Fortemente da comprare

Previsioni per 12 mesi

+27.94% upside

Dividendi

By Dow Jones

Rendimento da dividendi

Media del settore

0.31%

2.37%

Prossima data del Dividendo

4 feb 2026

Prossima data del' Ex Dividendo

28 gen 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-209M

20B

Apertura precedente

275.02

Chiusura precedente

274.87

Notizie sul Sentiment di mercato

By Acuity

50%

50%

166 / 374 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Strong Bullish Evidence

West Pharmaceutical Services Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

22 dic 2025, 23:54 UTC

I principali Market Mover

Novo Nordisk ADRs Gain on FDA Approval of First GLP-1 in Pill Form

22 dic 2025, 19:08 UTC

Acquisizioni, Fusioni, Takeovers

Correction to Alphabet to Buy Intersect Article

22 dic 2025, 17:21 UTC

Acquisizioni, Fusioni, Takeovers

Alphabet to Buy Intersect for $4.75 Billion as AI-Investment Plans Grow -- Update

22 dic 2025, 16:46 UTC

Acquisizioni, Fusioni, Takeovers

Alphabet to Buy Intersect for $4.75 Billion in Cash

22 dic 2025, 23:50 UTC

Discorsi di Mercato

Nikkei May Decline as Yen Rebounds -- Market Talk

22 dic 2025, 23:42 UTC

Discorsi di Mercato

Gold Hits Record High Amid Rising Geopolitical Risks -- Market Talk

22 dic 2025, 22:31 UTC

Utili

Zhejiang Sanhua Intelligent Controls: Higher Demand for Air-Conditioning Components Supported Results >002050.SZ

22 dic 2025, 22:31 UTC

Utili

Zhejiang Sanhua Intelligent Controls: Higher Demand for Refrigeration Supported Results >002050.SZ

22 dic 2025, 22:30 UTC

Utili

Zhejiang Sanhua Intelligent Controls Sees 2025 Net CNY3.87B, Up 25% on Year >002050.SZ

22 dic 2025, 21:50 UTC

Discorsi di Mercato

Basic Materials Roundup: Market Talk

22 dic 2025, 21:50 UTC

Discorsi di Mercato

Health Care Roundup: Market Talk

22 dic 2025, 21:37 UTC

Acquisizioni, Fusioni, Takeovers

Capricorn: Project Is Contiguous to Capricorn's Golden Range, Fields Find Tenure

22 dic 2025, 21:36 UTC

Acquisizioni, Fusioni, Takeovers

Capricorn to Pay A$500,000 Cash, A$4M in New Shares

22 dic 2025, 21:35 UTC

Acquisizioni, Fusioni, Takeovers

Capricorn to Acquire Prospective Package From Tempest Minerals

22 dic 2025, 21:35 UTC

Acquisizioni, Fusioni, Takeovers

Capricorn Metals to Buy Yalgoo Project Tenement Package for A$4.5M

22 dic 2025, 20:54 UTC

Acquisizioni, Fusioni, Takeovers

Middle West Partners Buys Paul Stuart From Mitsui & Co.

22 dic 2025, 20:52 UTC

Acquisizioni, Fusioni, Takeovers

HCL Technologies: HCLSoftware to Acquire Jaspersoft From Cloud Software Group >532281.BY

22 dic 2025, 20:09 UTC

Discorsi di Mercato

U.S. Natural Gas Settles Lower in Choppy Trade -- Market Talk

22 dic 2025, 19:56 UTC

Discorsi di Mercato

Crude Gains as U.S. Increases Actions Against Venezuela -- Market Talk

22 dic 2025, 19:49 UTC

Acquisizioni, Fusioni, Takeovers

A Topsy-Turvy Year for Oracle and the Ellisons Will Bleed into 2026 -- Barrons.com

22 dic 2025, 19:23 UTC

Discorsi di Mercato

Mexico's Inflation Seen Easing in Early December -- Market Talk

22 dic 2025, 19:23 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

22 dic 2025, 19:02 UTC

Discorsi di Mercato

Global Energy Roundup: Market Talk

22 dic 2025, 19:02 UTC

Discorsi di Mercato

Precious Metals Climb to New Heights -- Market Talk

22 dic 2025, 18:45 UTC

Discorsi di Mercato

Canadian Trade-Exposed Industries At Forefront of Job Weakness -- Market Talk

22 dic 2025, 18:30 UTC

Discorsi di Mercato
Acquisizioni, Fusioni, Takeovers

Intersect Selling Portion of Assets as Part of Alphabet Deal -- Market Talk

22 dic 2025, 18:23 UTC

Acquisizioni, Fusioni, Takeovers

What Yogi Berra Would Say About the Talks to Take Over Warner Bros. Discovery -- Barrons.com

22 dic 2025, 17:20 UTC

Discorsi di Mercato

Health Care Roundup: Market Talk

22 dic 2025, 17:15 UTC

Discorsi di Mercato

Global Commodities Roundup: Market Talk

22 dic 2025, 17:06 UTC

Acquisizioni, Fusioni, Takeovers

Alphabet to Buy Intersect for $4.75B as AI-Investment Plans Grow -- Update

Confronto tra pari

Modifica del prezzo

West Pharmaceutical Services Inc Previsione

Obiettivo di Prezzo

By TipRanks

27.94% in crescita

Previsioni per 12 mesi

Media 348.7 USD  27.94%

Alto 375 USD

Basso 285 USD

Basato su 12 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per West Pharmaceutical Services Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

12 ratings

10

Acquista

2

Mantieni

0

Vendi

Punteggio Tecnico

By Trading Central

213.26 / 219.27Supporto e resistenza

A breve termine

Strong Bullish Evidence

A termine intermedio

Bearish Evidence

A lungo termine

Bearish Evidence

Sentiment

By Acuity

166 / 374 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Neutral

Volatilità

Sotto la media

Volume delle notizie (RCV)

Media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo West Pharmaceutical Services Inc

West Pharmaceutical Services, Inc. is a global manufacturer in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. Its products include various primary packaging, containment solutions, reconstitution, and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services, and integrated solutions. The Company’s segments include Proprietary Products and Contract-Manufactured Products. Proprietary Products reportable segment offers proprietary packaging, containment, and drug delivery products, along with analytical lab services and other integrated services. Contract-Manufactured Products segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
help-icon Live chat